Journal article Open Access

EVIDENCE FOR TREATING RHEUMATOID ARTHRITIS: A REVIEW WITH SPECIAL ATTENTION IN CLINICAL MANIFESTATIONS

Deevan Paul A, C Swetha*, G Jyothi Reddy, P Ramyasri, Avilala Neelima


MARC21 XML Export

<?xml version='1.0' encoding='UTF-8'?>
<record xmlns="http://www.loc.gov/MARC21/slim">
  <leader>00000nam##2200000uu#4500</leader>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">Rheumatoid Arthritis, Auto Immune Disease, Synovial Cavity, Pharmacokinetics and Pharmacodynamic Profiles.</subfield>
  </datafield>
  <controlfield tag="005">20200803125922.0</controlfield>
  <controlfield tag="001">3970367</controlfield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="s">975419</subfield>
    <subfield code="z">md5:79bff5cc5bf482459b6f6d3a50c32166</subfield>
    <subfield code="u">https://zenodo.org/record/3970367/files/200211.pdf</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="l">open</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2020-08-03</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="p">openaire</subfield>
    <subfield code="p">user-iajpr</subfield>
    <subfield code="o">oai:zenodo.org:3970367</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="u">SVU College of Pharmaceutical Sciences, SV University.</subfield>
    <subfield code="a">Deevan Paul A, C Swetha*, G Jyothi Reddy, P Ramyasri, Avilala Neelima</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">EVIDENCE FOR TREATING RHEUMATOID ARTHRITIS: A REVIEW WITH SPECIAL ATTENTION IN CLINICAL MANIFESTATIONS</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">user-iajpr</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="u">https://creativecommons.org/licenses/by/4.0/legalcode</subfield>
    <subfield code="a">Creative Commons Attribution 4.0 International</subfield>
  </datafield>
  <datafield tag="650" ind1="1" ind2="7">
    <subfield code="a">cc-by</subfield>
    <subfield code="2">opendefinition.org</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">&lt;p&gt;Rheumatoid Arthritis (RA) is an auto immune disease that affects in the clinical manifestations of arthritis in each patient. In addition to the development of medication, the clinical manifestations are to achieve the most effective role with less side effects by improving the pharmacokinetic and pharmacodynamic profiles. Multiple environmental factors including hormones, dietary factors, infections and exposure tobacco smoke as well as associated with increased risk for rheumatoid arthritis. Concurrently have proven in effective by retaining the therapeutic index at synovial cavity by virtue of its diagnostic medication. Current trends and future perspectives imply that definitive role in drug release are controlled by biological modifications in the anti-rheumatic drugs behaves the significant characteristic in achieving the disease remission without joint deformity.&lt;/p&gt;</subfield>
  </datafield>
  <datafield tag="773" ind1=" " ind2=" ">
    <subfield code="n">doi</subfield>
    <subfield code="i">isVersionOf</subfield>
    <subfield code="a">10.5281/zenodo.3970366</subfield>
  </datafield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="a">10.5281/zenodo.3970367</subfield>
    <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">publication</subfield>
    <subfield code="b">article</subfield>
  </datafield>
</record>
45
19
views
downloads
All versions This version
Views 4545
Downloads 1919
Data volume 18.5 MB18.5 MB
Unique views 4242
Unique downloads 1818

Share

Cite as